FDA responds to provider pressure, backs off stricter control of fecal transplants for C. diff
By
McKnight's Staff
Jun 19, 2013
Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers,...
Efforts to combat Clostridium difficile are coming up short, survey finds
By
McKnight's Staff
Mar 12, 2013
Long-term care operators and other healthcare providers are having limited success in combating Clostridium difficile infections, despite increasing their efforts in the last three years, according to...
HHS healthcare-associated infection reduction plan is open for public comments
By
McKnight's Staff
Apr 20, 2012
The Department of Health and Human Services is seeking public comments on its updated action plan — which includes efforts in nursing homes — to reduce or eliminate healthcare-associated infections.
Fecal transplants to treat C. diff now need FDA approval
By
McKnight's Staff
May 17, 2013
The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.
New tracking tools, guidance help nursing homes treat and prevent facility-acquired infections
By
McKnight's Staff
Sep 19, 2012
Government health officials have released a tracking tool that can help nursing homes monitor healthcare-acquired infections.
Study reveals that ultraviolet light eliminates deadly hospital-acquired infections
By
McKnight's Staff
Oct 19, 2012
Researchers say they nearly eliminated deadly antibiotic-resistant bacteria in a study encompassing 50 patient rooms at two medical facilities by using a specific spectrum of ultraviolet light.
Depressed, lonely seniors are more likely to get C. diff, researchers find
By
McKnight's Staff
May 09, 2013
People who are depressed or lonely are at increased risk of Clostridium difficile infection, according to recently published research.
Limiting use of common antihistamines could reduce C. diff in facilities, researchers say
By
McKnight's Staff
Mar 29, 2013
Taking antihistamines such as Tagamet, Pepcid and Zantac increases the risk that people in healthcare settings will be infected with Clostridium difficile, according to a recently published study.